Childhood-onset severe hypereosinophilic asthma: efficacy of benralizumab

Jocelyne Just; Melisande Bourgoin; Flore Amat; Nathalie Cottel; Nathalie Lambert; Stephanie Wanin

doi:10.1183/23120541.00339-2020

Childhood-onset severe hypereosinophilic asthma: efficacy of benralizumab

ERJ Open Res. 2020 Dec 21;6(4):00339-2020. doi: 10.1183/23120541.00339-2020. eCollection 2020 Oct.

Authors

Jocelyne Just^{1

2}, Melisande Bourgoin^{1

2}, Flore Amat^{1

2}, Nathalie Cottel¹, Nathalie Lambert^{1

2}, Stephanie Wanin^{1

2}

Affiliations

¹ AP-HP, Groupe hospitalier Trousseau-La Roche Guyon, Centre de l'Asthme et des Allergies, Paris, France.
² Sorbonne - université, Paris, France.

Abstract

Severe hypereosinophilic asthma in children is extremely rare. This letter adds to the existing literature by providing long-term follow-up, and is the first report of the marked efficacy of benralizumab after failure of other biologic treatments. https://bit.ly/2G7Tc2k.